Hospital Specialty Pharmacies and 340B
Listen to Health Affairs' Leslie Erdelack and Jessica Bylander take
a break from government shutdown and Capitol Hill news to discuss
the latest on hospital specialty pharmacies and 340B drug pricing.
10 Minuten
Podcast
Podcaster
Health Affairs This Week places listeners at the center of health policy’s proverbial water cooler.
Beschreibung
vor 4 Jahren
This week was a busy week on Capitol Hill but on today's episode
of Health Affairs This Week, Senior Editors Leslie Erdelack and
Jessica Bylander look into recent pharmaceutical and drug pricing
news.
In one story, Walgreens is investing more into hospital specialty
pharmacies to broaden their reach. “Today, around 25 percent of
hospitals in the US have an in-house specialty pharmacy—that’s up
from 9 percent from just a few years,” says Erdelack.
In another story, a dust up over 340B drug pricing program is
playing out between drug companies and the federal government.
Take a break from government shutdown and Capitol Hill news and
listen to Health Affairs' Leslie Erdelack and Jessica Bylander
give an overview on the latest on the pharmaceutical industry.
Related Links:
6 Drug Companies Could Face Steep Fines For Violating 340B
Law (Healthcare Dive)
Walgreens Invests Deeper in Hospital Specialty Pharmacies
(Axios)
340B Drug Pricing Program (Health Resources & Services
Administration)
Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher |
Deezer | Overcast
Weitere Episoden
20 Minuten
vor 2 Wochen
18 Minuten
vor 3 Wochen
17 Minuten
vor 1 Monat
15 Minuten
vor 1 Monat
17 Minuten
vor 1 Monat
In Podcasts werben
Kommentare (0)